ELV Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio16.59Forward 14.62
EPS (TTM)$23.59-16.8% YoY
Profit margin2.6%HEALTHCARE
Market cap$84.97BLarge cap
Wall Street coverage
$415.81median target· current $534.79 (-22.2%)22 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 14.62
- PEG ratio
- 1.43
- P/B
- 1.94
- P/S (TTM)
- 0.42
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 12.1%
- Operating margin
- 5.3%
- Revenue growth YoY
- 2.6%
- Dividend yield
- 1.7%
- Beta
- 0.68
Last earnings
Apr 22, 2026 · Estimate $10.81 · Reported $12.58
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
27 articles · sorted by datePage 1 of 2 · 27 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Elevance Health Inc
Company profileElevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
Classification
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 220 VIRGINIA AVENUE, INDIANAPOLIS, IN
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$84.97B
Shares outstanding$217.2M
52W high$426.98
52W low$268.08
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent